| CASE REPORTS |
|
| Year : 2020 | Volume
: 11
| Issue : 3 | Page : 144-147 |
|
|
Telemedicine for the initial management of newly diagnosed gestational diabetes in the pandemic period: A report of three case studies
Monie Riju Simon1, Nikita Sarkar1, Suganthi Kumaran1, Anil Chittake2, Vedavati Purandare1, Ambika Gopalakrishnan Unnikrishnan1
1 Department of Endocrinology, Chellaram Diabetes Institute, Maharashtra, India
2 Department of Obstetrics and Gynecology, Embrio – The Centre for Assisted Reproduction, Pune, Maharashtra, India
Correspondence Address:
Dr. Ambika Gopalakrishnan Unnikrishnan
Department of Endocrinology, Chellaram Diabetes Institute, Lalani Quantum, Pune-Bangalore Highway, Bavdhan Budruk, Pune, Maharashtra.
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/JOD.JOD_44_20
|
|
|
Amidst the coronavirus disease of 2019 (COVID-19) pandemic and the subsequent guidance regarding movement restrictions, people may not be able to or willing to visit hospitals for a diabetes consultation. This especially applies to women with gestational diabetes mellitus (GDM) who are worried about getting infected during their visit to hospital. National telemedicine guidelines have now paved the way for using telemedicine for clinical care in India. We describe a series of three cases, where telemedicine aided the management of GDM. Aided by the use of digital technology, along with glucometers which synchronize with mobile phones and store data in the cloud for clinicians to access, we suggest that telemedicine could be considered in management of hyperglycemia in pregnancy in the current scenario. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
